Keywords: Alzheimer’s disease, amyloid, biomarkers, clinical trials, Common Alzheimer’s Disease Research Ontology (CADRO), drug development, inflammation, pharmaceutical companies, repurposed drugs,…
Abstract Neurodegenerative tauopathies are caused by the transition of tau protein from a monomer to a toxic aggregate. They include…
Abstract Alzheimer’s disease (AD) is a frequent and disabling neurodegenerative disorder, in which astrocytes participate in several pathophysiological processes including…
Abstract Tauopathies consist of over 25 different neurodegenerative diseases that include argyrophilic grain disease (AGD), progressive supranuclear palsy (PSP), corticobasal…
Abstract Background: Because of their low levels of expression and the inadequacy of current research tools, CB2 cannabinoid receptors (CB2R)…